Original language | English |
---|---|
Pages (from-to) | 106329 |
Journal | Journal of Stroke & Cerebrovascular Diseases |
Volume | 31 |
Issue number | 4 |
Early online date | 3 Feb 2022 |
DOIs | |
Publication status | E-pub ahead of print - 3 Feb 2022 |
Access to Document
- Bosch SAGEA NAVIGATE ESUS BASELINE manuscript 2022JAN01[1]
This is the author's peer-reviewed manuscript as accepted for publication.
Accepted author manuscript, 72.4 KBLicence: CC BY-NC-ND - Bosch SAGEA NAVIGATE ESUS BASELINE Tables 2022JAN01[1]
This is the author's peer-reviewed manuscript (tables) as accepted for publication.
Accepted author manuscript, 21.6 KBLicence: CC BY-NC-ND - Bosch SAGEA NAVIGATE ESUS BASELINE Appendix 2022JAN01[1]
This is the author's peer-reviewed manuscript (appendix) as accepted for publication.
Accepted author manuscript, 17.5 KBLicence: CC BY-NC-ND
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale. / Bosch, Jackie; Pearce, Lesly A.; Sharma, Mike et al.
In: Journal of Stroke & Cerebrovascular Diseases, Vol. 31, No. 4, 03.02.2022, p. 106329.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Functional Abilities of an International Post-Stroke Population: Standard Assessment of Global Everyday Activities (SAGEA) Scale
AU - Bosch, Jackie
AU - Pearce, Lesly A.
AU - Sharma, Mike
AU - Mikulík, Robert
AU - Whiteley, William N.
AU - Canavan, Michelle
AU - Hart, Robert G.
AU - O'donnell, Martin J.
N1 - Funding Information: J.B. received fees for an Advisory Board and as an Adjudication Committee Member from Bayer, outside the submitted work. M.S. reports personal fees from BMS and Daichii Sankyo, outside the submitted work. M.C. received a travel grant from Boehringer Ingelheim and Bayer for conference attendance. W.W. is supported by a Scottish Senior Clinical Fellowship [CSO SCAF/17/01] and received grants from the Alzheimer's Society [UK], Chief Scientist's Office, UK MRC, and the UK Stroke Association. S.Y. is supported by the Heart & Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease and has received research grants, honoraria and travel expenses for lectures from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb AstraZeneca and Sanofi, outside the submitted work. R.H. reports grants and personal fees from Bayer AG, outside the submitted work. Funding Information: The NAVIGATE ESUS trial was sponsored by Bayer AG. Publisher Copyright: © 2022
PY - 2022/2/3
Y1 - 2022/2/3
U2 - 10.1016/j.jstrokecerebrovasdis.2022.106329
DO - 10.1016/j.jstrokecerebrovasdis.2022.106329
M3 - Article
VL - 31
SP - 106329
JO - Journal of Stroke & Cerebrovascular Diseases
JF - Journal of Stroke & Cerebrovascular Diseases
SN - 1052-3057
IS - 4
ER -